Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP block for pain management in rib fracture patients
NCT03805360Phase 1Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- May 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ropivacaine in rib fracture, sponsored by Virginia Commonwealth University. Primary endpoints: Numeric pain score rating at rest at 45 minutes and Numeric pain score rating with respiration at 45 minutes. Started May 2019; status: terminated.
02
Drugs
ropivacaine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT03805360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03805360.